Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    15684639 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Rosiglitazone-Induced Weight Gain
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Rosiglitazone;   Behavioral: dietary recommendation for weight maintenance

Study has passed its completion date and status has not been verified in more than two years.